The partnerships allow Bionovis to access cutting-edge technology and training, enabling the company, in the short term, to operate in the production and commercialization of highly complex biological and biosimilar medicines.
Bionovis is engaged in the prospection of products and scientific resources for licensing and technology transfer and is qualified to develop new drugs, as well as to partner in the production of medicines for clinical studies or industrial-scale manufacturing.
Bionovis focuses on the development, production, and commercialization of biopharmaceuticals. To this end, the company identifies molecules of interest, aiming to develop them and make them available to both national and international markets through various partnership models.
We work on prospecting products for licensing with or without technology transfer. Under this model, products can be manufactured by Bionovis and sold in the private sector.
Bionovis focuses on the development, production and commercialization of biopharmaceuticals.
To this end, the company identifies molecules of interest, aiming to develop and make them available to the national and international market through various partnership formats.
Developing a new drug is a process that can take decades of research and cost hundreds of millions of dollars. Therefore, Bionovis seeks partners to join efforts in the production of new medicines.
Contract Manufacturing Organizations (CMO) enable pharmaceutical companies to outsource certain aspects of their operations, such as the large-scale manufacturing of biopharmaceuticals or the production of clinical batches for scientific trials. Bionovis offers these services at its industrial plant, located in Valinhos, São Paulo.
We are driven by the pride of being part of Brazil’s transformation in healthcare.
Being a Bionovis partner means investing in Brazil’s self-sufficiency, in the generation of jobs and income and in the democratization of access to healthcare for the entire population.
Bionovis Team
For more than a decade, we have built partnerships with major global leaders in the pharmaceutical industry and public laboratories, such as Bio-Manguinhos/FIOCRUZ, Fresenius Kabi, Johnson & Johnson Innovative Medicine, Merck, Samsung Bioepis, and Sandoz.
Through these partnerships, we receive complete technology for the production of innovative biopharmaceuticals and biosimilars.
In addition, we have signed commercialization agreements for the private market, with INTAS, mAbxience, and Samsung Bioepis.
Through these partnerships, we receive the complete technology for the production of innovative biopharmaceuticals and biosimilars.
In addition, we have signed partnerships for commercialization in the private market, with INTAS, mAbxience and Samsung Bioepis.
Bionovis is a pioneer in the production and commercialization of biological and biosimilar medicines.
Our pursuit of scientific innovations and highly complex medicines aims to build a healthier Brazil — and a healthier world — for everyone.
© 2025 Bionovis. Companhia Brasileira de Biotecnologia Farmacêutica.
